|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory, net (Note 5) | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Property and equipment, net (Note 6) | ||||||||||||||||||||
| Intangible and other assets, net (Note 7) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current portion of long-term debt and capital lease obligations | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Accrued product development expenses | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Current portion of deferred executive compensation | ||||||||||||||||||||
| Current portion of deferred revenue | ||||||||||||||||||||
| Other current liabilities (Note 8) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible 3.625% senior notes, net | ||||||||||||||||||||
| Other long-term debt | ||||||||||||||||||||
| Long-term facility lease obligation | ||||||||||||||||||||
| Long-term debt (Note 9) | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity (deficit): | ||||||||||||||||||||
| Preferred stock, $.01 par value, authorized 10,000,000 shares, none issued and outstanding | ||||||||||||||||||||
| Common stock, $.001 par value, authorized 450,000,000 shares; issued and outstanding 194,091,892 shares in 2016 and 189,662,148 shares in 2015 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | ||||||||||||||||||||
Loading...
